196 related articles for article (PubMed ID: 15537056)
1. Overview of target validation and the impact of oligonucleotides.
Jones SW; Lindsay MA
Curr Opin Mol Ther; 2004 Oct; 6(5):546-50. PubMed ID: 15537056
[TBL] [Abstract][Full Text] [Related]
2. RNA interference: the silent treatment.
Clayton J
Nature; 2004 Sep; 431(7008):599-605. PubMed ID: 15457267
[No Abstract] [Full Text] [Related]
3. Aptamers as tools for target validation.
Blank M; Blind M
Curr Opin Chem Biol; 2005 Aug; 9(4):336-42. PubMed ID: 16006181
[TBL] [Abstract][Full Text] [Related]
4. Application of antisense oligonucleotides for gene functionalization and target validation.
Bennett CF; Cowsert LM
Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801
[TBL] [Abstract][Full Text] [Related]
5. Antisense and RNA interference approaches to target validation in pain research.
Kurreck J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):179-87. PubMed ID: 15603251
[TBL] [Abstract][Full Text] [Related]
6. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
7. LNA-antisense rivals siRNA for gene silencing.
Jepsen JS; Wengel J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
[TBL] [Abstract][Full Text] [Related]
8. siRNA-based approaches in cancer therapy.
Devi GR
Cancer Gene Ther; 2006 Sep; 13(9):819-29. PubMed ID: 16424918
[TBL] [Abstract][Full Text] [Related]
9. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
10. siRNAs in drug discovery: target validation and beyond.
Natt F
Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022
[TBL] [Abstract][Full Text] [Related]
11. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA.
de Martimprey H; Vauthier C; Malvy C; Couvreur P
Eur J Pharm Biopharm; 2009 Mar; 71(3):490-504. PubMed ID: 18977435
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo pharmacologic activities of antisense oligonucleotides.
Mirabelli CK; Bennett CF; Anderson K; Crooke ST
Anticancer Drug Des; 1991 Dec; 6(6):647-61. PubMed ID: 1663361
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotides for target validation in the CNS.
Ho SP; Hartig PR
Curr Opin Mol Ther; 1999 Jun; 1(3):336-43. PubMed ID: 11713799
[TBL] [Abstract][Full Text] [Related]
14. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.
Fattal E; Bochot A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1203-23. PubMed ID: 17097190
[TBL] [Abstract][Full Text] [Related]
15. Sugar boost: when ribose modifications improve oligonucleotide performance.
Faria M; Ulrich H
Curr Opin Mol Ther; 2008 Apr; 10(2):168-75. PubMed ID: 18386229
[TBL] [Abstract][Full Text] [Related]
16. Making antisense of splicing.
Garcia-Blanco MA
Curr Opin Mol Ther; 2005 Oct; 7(5):476-82. PubMed ID: 16248283
[TBL] [Abstract][Full Text] [Related]
17. 2'-O-Lysylaminohexyl oligonucleotides: modifications for antisense and siRNA.
Winkler J; Gilbert M; Kocourková A; Stessl M; Noe CR
ChemMedChem; 2008 Jan; 3(1):102-10. PubMed ID: 17979170
[TBL] [Abstract][Full Text] [Related]
18. The development and future of oligonucleotide-based therapies for cervical cancer.
Gu W; Putral LN; Irving A; McMillan NA
Curr Opin Mol Ther; 2007 Apr; 9(2):126-31. PubMed ID: 17458165
[TBL] [Abstract][Full Text] [Related]
19. Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3.
Dutkiewicz M; Grunert HP; Zeichhardt H; Lena SW; Wengel J; Kurreck J
FEBS Lett; 2008 Sep; 582(20):3061-6. PubMed ID: 18691577
[TBL] [Abstract][Full Text] [Related]
20. Managing the sequence-specificity of antisense oligonucleotides in drug discovery.
Hagedorn PH; Hansen BR; Koch T; Lindow M
Nucleic Acids Res; 2017 Mar; 45(5):2262-2282. PubMed ID: 28426096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
